---
schema_version: "secwatch.filing_event.v1"
accession: "0001628908-25-000069"
form_type: "8-K"
ticker: "EVH"
cik: "0001628908"
company_name: "Evolent Health, Inc."
filed_at: "2025-06-03T23:59:59+00:00"
generated_at: "2026-05-20T01:41:10.865833+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Evolent Health reaffirms FY2025 revenue guidance of $2.06B-$2.11B at William Blair conference

## Summary
- Reaffirms FY2025 revenue guidance of $2.06B-$2.11B and Adjusted EBITDA of $135M-$165M.
- Q2 2025 revenue guidance reaffirmed at $440M-$470M; Adj EBITDA $33M-$40M.
- Guidance unchanged from the May 8, 2025 press release; no new financial targets.

## SEC filing metadata
- accession: 0001628908-25-000069
- form_type: 8-K
- ticker: EVH
- cik: 0001628908
- company_name: Evolent Health, Inc.
- filed_at: 2025-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628908/000162890825000069/0001628908-25-000069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628908/000162890825000069/evh-20250603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628908-25-000069
- JSON: https://secwatch.observer/filing/0001628908-25-000069.json
- Plain text: https://secwatch.observer/filing/0001628908-25-000069.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.